BRLI Announces InCellDx Investment and Launch of GenCerv Test Through its ... EON: Enhanced Online News (press release) ... Inc. (“InCellDx”), a privately held molecular diagnostics start-up company dedicated to the detection and monitoring of life -threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis and organ transplant rejection. Bio-Reference Labs Investing up to $6M in InCellDx |
